Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Vyora Wellness vs Willow

Vyora Wellness
Graded #321

Higher grade

vs+2.299999999999997
Willow
Graded #377

Lower grade

The verdict

Vyora Wellness takes it — 60.5/100 to 58.2/100.

Vyora Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vyora Wellness offers compounded semaglutide ($299/mo) and compounded tirzepatide ($399/mo) as 4-week subscription plans.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVyora Wellness +6
42
36
Dose & formulationWillow +11
64
75
Clinical oversightVyora Wellness +8
79
71
Labs & monitoringVyora Wellness +8
60
52
FulfillmentVyora Wellness +2
67
65
Contract termsEven
55
55
Vyora Wellness · left barWillow · right bar

The numbers

MetricVyora WellnessWillow
WeighScore60.5/10058.2/100
GradeCC
Scorecard rank#321#377
Semaglutide$299/mo (compounded)$299/mo (starting dose, compounded)
Tirzepatide$399/mo (compounded)$399/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Vyora Wellness

Graded #321 · C

Strengths

  • LegitScript certified
  • Price includes nutritional guidance, 24/7 coaching, and community access
  • Both semaglutide and tirzepatide available
  • BMI 25+ eligibility threshold (lower than some competitors)

Where it loses points

  • State availability not publicly disclosed
  • Pricing is above average ($299–$399/mo) compared to competitors
  • Compounded only — no brand-name options
  • Broader platform (metabolic, longevity, topical products)
Willow

Graded #377 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard